Background
Examining the HIV-1 reservoir during periods of immune “reset” may uncover pathways that could lead to novel strategies for activation and eventual clearance of latently infected cells. Lymphocyte-depleting agents such as anti-thymocyte globulin (ATG) provide a unique real-world in vivo model to examine how immune depletion and reconstitution might influence HIV reservoir changes.
Methods
We conducted a retrospective longitudinal cohort study using stored PBMC samples from kidney transplant recipients with HIV (n=21) who received kidneys from HIV-positive deceased donors in South Africa. All recipients received ATG as an induction immunosuppressant at transplantation, as well as immunosuppressive therapy post-transplant. Latent HIV-1 reservoirs were quantified as translational-competent units per million (TCUPM) CD4+ T cells using an adapted limiting dilution version of the ultrasensitive p24 TRACER assay. TCUPM data was analysed using a previously validated Bayesian model for limiting dilution reservoir assays. Individual slopes of change in reservoir size were divided into recipients with >median (high), and ≤ median (low group) and outcomes were analysed by Kaplan-Meier for patient survival and graft survival.
Results
A total of 86 time points were available including pre-transplant and up to 8 years post-transplant (median follow-up of 2.5 years). We observed a significant increase in TCUPM CD4+ T cells across the cohort (mean change = 0.47 ; 95% CI: 0.17–0.77), with six individuals showing significant increases in their reservoirs and none demonstrating significant declines. Kaplan-Meier analyses of outcomes in individuals in the high group suggested a trend toward reduced patient survival among individuals with increasing reservoirs (p=0.09), whereas those with lower or stable slopes appeared more prone to graft failure.
Conclusions
These results suggest a possible dichotomy between immune-mediated control of the HIV reservoir and transplant outcomes that warrant further investigation. While ATG therapy is not a viable Cure strategy for PLWH, it provides a unique opportunity to study how immune perturbations influence latent reservoir dynamics and may help to better define the underlying mechanisms of reservoir maintenance.